Compare
Amphstar Pharmaceuticals vs Merck & (AMPH vs MRK)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Amphstar Pharmaceuticals (AMPH) returned +12.6% and Merck & (MRK) +73.9%; so far this year the figures are +6.4% and +39.4%.
Merck & is the larger company by market value, about 296.5 times the size of Amphstar Pharmaceuticals.
On trailing earnings, AMPH trades at 13.0 times and MRK at 149.7 times.
Revenue grew +3.1% at AMPH and +4.9% at MRK over the last year.
AMPH pays no dividend. MRK yields 2.32%.
Data as of the latest close. Not investment advice.
Relative performance
| AMPH | MRK | |
|---|---|---|
| Price | $28.49 | $146.73 |
| 1-day | +3.00% | -0.14% |
| YTD | +6.39% | +39.40% |
| 1 year | +12.56% | +73.87% |
| 3 years | -37.30% | +42.66% |
| Market cap | $1.2B | $361.7B |
| P/E | 13.0 | 149.7 |
| P/S | 1.63 | 5.37 |
| P/B | 1.49 | 8.06 |
| Revenue growth | +3.10% | +4.90% |
| EPS growth | -3.10% | -87.10% |
| Gross margin % | 46.8 | 71.8 |
| Net margin % | 13.3 | 3.6 |
| ROE % | 12.1 | 5.5 |
| Debt / equity | 0.75 | 1.20 |
| FCF yield % | 11.4 | 4.1 |
| Dividend yield % | — | 2.32 |
| Beta | 0.55 | 0.18 |
| RSI (14) | 66.7 | 51.3 |
| Technical rating |